Senthil Sundaram
2022
In 2022, Senthil Sundaram earned a total compensation of $2M as Chief Executive Officer at Terns Pharmaceuticals, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $421,050 |
|---|---|
| Option Awards | $971,986 |
| Salary | $561,400 |
| Other | $12,200 |
| Total | $1,966,636 |
Sundaram received $972K in option awards, accounting for 49% of the total pay in 2022.
Sundaram also received $421.1K in non-equity incentive plan, $561.4K in salary and $12.2K in other compensation.
Rankings
In 2022, Senthil Sundaram's compensation ranked 1,763rd out of 5,616 executives tracked by ExecPay. In other words, Sundaram earned more than 68.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,763 out of 5,616 | 69th |
Division Manufacturing | 924 out of 3,048 | 70th |
Major group Chemicals And Allied Products | 369 out of 1,375 | 73rd |
Industry group Drugs | 337 out of 1,276 | 74th |
Industry Pharmaceutical Preparations | 243 out of 924 | 74th |
Source: SEC filing on April 28, 2023.
Sundaram's colleagues
We found two more compensation records of executives who worked with Senthil Sundaram at Terns Pharmaceuticals in 2022.